{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:19Z","timestamp":1759451959002,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010757","name":"National Centre for the Replacement Refinement and Reduction of Animals in Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010757","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.11.005","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T09:04:48Z","timestamp":1574240688000},"page":"1241-1248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen"],"prefix":"10.1016","volume":"38","author":[{"given":"Lucia","family":"Biffar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Blunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Holder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Vordermeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-5142","authenticated-orcid":false,"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Villarreal-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.005_b0005","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3201\/eid1906.120543","article-title":"Zoonotic Mycobacterium bovis-induced tuberculosis in humans","volume":"19","author":"Muller","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.005_b0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12879-016-2001-5","article-title":"Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000\u20132015","volume":"16","author":"Torres-Gonzalez","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.005_b0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(18)30013-6","article-title":"A roadmap for zoonotic tuberculosis: a One Health approach to ending tuberculosis","volume":"18","author":"Dean","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.005_b0020","unstructured":"WHO. The control of neglected zoonotic diseases: A route to poverty alleviation. Report of a Joint WHO\/DFID-AHP Meeting with the participation of FAO and OIE Geneva; 2006."},{"key":"10.1016\/j.vaccine.2019.11.005_b0025","unstructured":"DEFRA. The strategy for achieving officially bovine tuberculosis free status for England. UK government, DEFRA; 2014."},{"key":"10.1016\/j.vaccine.2019.11.005_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.11.005_b0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0966-842X(00)88994-5","article-title":"Animal models of protective immunity in tuberculosis to evaluate candidate vaccines","volume":"3","author":"Griffin","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2019.11.005_b0040","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.vaccine.2012.02.018","article-title":"Bovine tuberculosis vaccine research: historical perspectives and recent advances","volume":"30","author":"Waters","year":"2012","journal-title":"Vaccine"},{"year":"1997","series-title":"Bovine tuberculosis in cattle and badgers","author":"Krebs","key":"10.1016\/j.vaccine.2019.11.005_b0045"},{"key":"10.1016\/j.vaccine.2019.11.005_b0050","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2014.08.009","article-title":"Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle","volume":"32","author":"Villarreal-Ramos","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.005_b0055","article-title":"B.R.L. The principles of humane","author":"Russel","year":"1959","journal-title":"Exp Tech"},{"key":"10.1016\/j.vaccine.2019.11.005_b0060","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"Vordermeier","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.11.005_b0065","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/IAI.74.2.1416-1418.2006","article-title":"Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG","volume":"74","author":"Vordermeier","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.11.005_b0070","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2013.11.045","article-title":"Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines","volume":"32","author":"Dean","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.005_b0075","doi-asserted-by":"crossref","first-page":"205ra134","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2019.11.005_b0080","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.11.005_b0085","doi-asserted-by":"crossref","first-page":"e29194","DOI":"10.1371\/journal.pone.0029194","article-title":"Development of an antibody to bovine IL-2 reveals multifunctional CD4 T(EM) cells in cattle naturally infected with bovine tuberculosis","volume":"6","author":"Whelan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.005_b0090","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/infdis\/jit647","article-title":"Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination","volume":"209","author":"Harris","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.005_b0095","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/jis012","article-title":"A human challenge model for mycobacterium tuberculosis using mycobacterium bovis bacille calmette-Gu\u00e9rin","volume":"205","author":"Minassian","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.005_b0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/infdis\/jiv482","article-title":"Optimization of a human bacille calmette-guerin challenge model: a tool to evaluate antimycobacterial immunity","volume":"213","author":"Minhinnick","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.005_b0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-animal-021815-111311","article-title":"Bovine tuberculosis in cattle: vaccines, DIVA tests, and host biomarker discovery","volume":"4","author":"Vordermeier","year":"2016","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.vaccine.2019.11.005_b0110","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.164.12.6417","article-title":"Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology","volume":"164","author":"Bosio","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.11.005_b0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.smim.2014.10.005","article-title":"The role of B cells and humoral immunity in Mycobacterium tuberculosis infection","volume":"26","author":"Chan","year":"2014","journal-title":"Semin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:12Z","timestamp":1759401732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19315129"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}